Gyre Therapeutics Inc (GYRE)

Sales/Maturities of Investments

$30.30M

TTM · Period ending: · USD

GYRE logo

GYRE Sales/Maturities of Investments

Latest reported$30.30M
GYRE TTM Sales/Maturities of Investments ($25.50M → $30.30M)
High-resolution chart · PNG

GYRE sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gyre Therapeutics Inc Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
30,304,000
14,312,000
15,429,000
11,190,000
11,190,000
11,190,000
0
0
0
0
0
-2,504,000
-2,504,000
-2,504,000
-2,504,000
2,866,000
10,396,000
21,447,000
49,028,000
79,644,999
95,703,999
101,688,999
107,564,999
97,548,000
118,921,000
142,616,000
157,433,000
201,597,000
186,279,000
162,304,000
127,967,000
67,837,000
38,193,000
21,436,000
14,300,000
10,201,000
12,601,000
16,803,000
10,002,000
17,674,000
15,274,000
21,679,000
42,704,000
45,875,000
56,078,000
52,947,000
40,991,000
41,223,000
49,483,000
62,492,000
69,882,000
85,655,000
112,568,000
127,243,000
159,538,000
168,059,000
138,942,000
124,503,000
100,012,000
71,883,000
83,964,000
94,744,000
84,481,000
73,840,000
58,500,000
51,000,000
41,000,000
54,037,423
65,400,005
62,334,000
101,334,000
169,150,927
170,951,108
160,653,439
130,408,543
61,554,193
49,391,430
38,755,104
26,000,000
29,000,000
25,500,000
25,500,000
25,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.